The paroxysmal supraventricular tachycardia mechanism
The paroxysmal supraventricular tachycardia mechanism Paroxysmal supraventricular tachycardia (PSVT) is a common arrhythmia characterized by sudden episodes of rapid heart rate originating above the ventricles. Understanding the mechanism of PSVT involves delving into the heart’s electrical conduction system, which coordinates the rhythmic contractions necessary for effective blood circulation. At its core, PSVT occurs due to abnormal electrical pathways or reentry circuits within the atria or the atrioventricular (AV) node, leading to episodes of rapid heartbeat that can last from seconds to hours.
The heart’s electrical activity begins in the sinoatrial (SA) node, the natural pacemaker, and travels through the atria to reach the AV node. The AV node then conducts impulses to the ventricles, ensuring coordinated contraction. In individuals with PSVT, the primary mechanism involves a reentrant circuit—a loop of electrical activity that perpetuates itself, causing rapid and repeated activation of the heart tissue. This reentry can occur in various parts of the conduction pathway, but most commonly involves the AV node and an accessory pathway. The paroxysmal supraventricular tachycardia mechanism
Accessory pathways are abnormal conduction routes that bypass the AV node, allowing electrical signals to travel prematurely or aberrantly between the atria and ventricles. When such a pathway exists, a reentrant circuit can form if the electrical impulse travels down one pathway and then re-enters the atrium through the accessory pathway, creating a self-sustaining loop. This loop results in a rapid heart rate, typically between 150 and 250 beats per minute, characteristic of PSVT.
The paroxysmal supraventricular tachycardia mechanism One of the most well-known forms of PSVT is atrioventricular reentrant tachycardia (AVRT), which involves both the AV node and an accessory pathway. In AVRT, the reentrant circuit involves an anterograde conduction through the AV node and a retrograde conduction through the accessory pathway. Another common form is atrioventricular nodal reentrant tachycardia (AVNRT), which involves a reentry circuit confined within or near the AV node itself, often due to dual pathways within the node: a fast pathway and a slow pathway. When a premature atrial contraction occurs, it can trigger the reentrant circuit within the AV node, leading to sudden onset and termination of tachycardia.
The initiation of PSVT typically involves a trigger, such as a premature atrial beat, and a substrate, which is the presence of dual pathways or accessory pathways capable of supporting reentry. The rapid episodes are often self-limited but can cause symptoms like palpitations, dizziness, or chest discomfort. In some cases, PSVT can compromise cardiac output or precipitate more serious arrhythmias if not managed appropriately. The paroxysmal supraventricular tachycardia mechanism
Diagnosis involves electrocardiogram (ECG) monitoring, which reveals narrow QRS complexes with a rapid rate during episodes. Electrophysiology studies can further clarify the specific pathway involved, guiding targeted treatments. Management strategies include vagal maneuvers to terminate the episodes, medications such as adenosine, beta-blockers, or calcium channel blockers, and invasive procedures like catheter ablation to destroy the abnormal pathways, offering a potential cure. The paroxysmal supraventricular tachycardia mechanism
The paroxysmal supraventricular tachycardia mechanism Understanding the mechanism of PSVT underscores the importance of precise diagnosis and targeted therapy. Although episodes can be alarming, effective treatments are available that can significantly improve quality of life and prevent serious complications. As research advances, new insights continue to enhance our ability to manage this common arrhythmia effectively.
